Rating History for Pacira Pharmaceuticals (PCRX) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for PCRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/9/2026 Douglas Tsao Downgrade Neutral
(Buy)		 36.50
(N/A)		 36.39
(36.34)		 -0.14% Details